321 related articles for article (PubMed ID: 23727188)
1. Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis.
Lee DH; Koo KC; Lee SH; Rha KH; Choi YD; Hong SJ; Chung BH
J Urol; 2013 Oct; 190(4):1213-7. PubMed ID: 23727188
[TBL] [Abstract][Full Text] [Related]
2. Low-risk prostate cancer patients without visible tumor (T1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol.
Lee DH; Koo KC; Lee SH; Rha KH; Choi YD; Hong SJ; Chung BH
Jpn J Clin Oncol; 2013 May; 43(5):553-8. PubMed ID: 23580758
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
4. Role of multiparametric 3.0-Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance.
Park BH; Jeon HG; Choo SH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
BJU Int; 2014 Jun; 113(6):864-70. PubMed ID: 24053308
[TBL] [Abstract][Full Text] [Related]
5. Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.
Mitsuzuka K; Narita S; Koie T; Kaiho Y; Tsuchiya N; Yoneyama T; Kakoi N; Kawamura S; Tochigi T; Habuchi T; Ohyama C; Arai Y
BJU Int; 2013 May; 111(6):914-20. PubMed ID: 23320782
[TBL] [Abstract][Full Text] [Related]
6. Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomies.
Jeong IG; Lim JH; You D; Kim MH; Choi HJ; Kim JK; Cho KS; Hong JH; Ahn H; Kim CS
J Urol; 2013 Dec; 190(6):2054-60. PubMed ID: 23791890
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance.
Kim TH; Jeong JY; Lee SW; Kim CK; Park BK; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Choi HY; Jeon SS
Eur Radiol; 2015 Jun; 25(6):1786-92. PubMed ID: 25636416
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted magnetic resonance imaging in prostate cancer patients on active surveillance one year after diagnosis and before repeat biopsy.
Vasarainen H; Lahdensuo K; Savolainen R; Ruutu M; Taari K; Rannikko A
Scand J Urol; 2013 Dec; 47(6):456-61. PubMed ID: 23327661
[TBL] [Abstract][Full Text] [Related]
10. Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study.
Chong Y; Kim CK; Park SY; Park BK; Kwon GY; Park JJ
AJR Am J Roentgenol; 2014 Apr; 202(4):772-7. PubMed ID: 24660705
[TBL] [Abstract][Full Text] [Related]
11. Ability of preoperative 3.0-Tesla magnetic resonance imaging to predict the absence of side-specific extracapsular extension of prostate cancer.
Hara T; Nakanishi H; Nakagawa T; Komiyama M; Kawahara T; Manabe T; Miyake M; Arai E; Kanai Y; Fujimoto H
Int J Urol; 2013 Oct; 20(10):993-9. PubMed ID: 23360237
[TBL] [Abstract][Full Text] [Related]
12. Extracapsular extension in prostate cancer: added value of diffusion-weighted MRI in patients with equivocal findings on T2-weighted imaging.
Woo S; Cho JY; Kim SY; Kim SH
AJR Am J Roentgenol; 2015 Feb; 204(2):W168-75. PubMed ID: 25615777
[TBL] [Abstract][Full Text] [Related]
13. Utility of diffusional kurtosis imaging as a marker of adverse pathologic outcomes among prostate cancer active surveillance candidates undergoing radical prostatectomy.
Rosenkrantz AB; Prabhu V; Sigmund EE; Babb JS; Deng FM; Taneja SS
AJR Am J Roentgenol; 2013 Oct; 201(4):840-6. PubMed ID: 24059373
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a structured report of functional prostate magnetic resonance imaging in patients with suspicion for prostate cancer or under active surveillance.
Quentin M; Blondin D; Klasen J; Schek J; Buchbender C; Miese FR; Antoch G; Barski D; Albers P; Arsov C
Urol Int; 2012; 89(1):25-9. PubMed ID: 22677880
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy.
Jeong IG; Kim JK; Cho KS; You D; Song C; Hong JH; Ahn H; Kim CS
J Urol; 2010 Nov; 184(5):1963-9. PubMed ID: 20851437
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
18. Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
Yim JH; Kim CK; Kim JH
J Magn Reson Imaging; 2018 Apr; 47(4):1072-1079. PubMed ID: 28901655
[TBL] [Abstract][Full Text] [Related]
19. Does suspicion of prostate cancer on integrated T2 and diffusion-weighted MRI predict more adverse pathology on radical prostatectomy?
Borofsky MS; Rosenkrantz AB; Abraham N; Jain R; Taneja SS
Urology; 2013 Jun; 81(6):1279-83. PubMed ID: 23394882
[TBL] [Abstract][Full Text] [Related]
20. Analysis of outcomes after radical prostatectomy in patients eligible for active surveillance (PRIAS).
El Hajj A; Ploussard G; de la Taille A; Allory Y; Vordos D; Hoznek A; Abbou CC; Salomon L
BJU Int; 2013 Jan; 111(1):53-9. PubMed ID: 22726582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
